GHSI - Guardion Health Sciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-20,537
-14,922
-24,745
-8,572
-10,878
Depreciation & amortization
1,396
1,249
907.548
219.6
625.786
Stock based compensation
-
-
0
-396.809
2,718
Change in working capital
-1,033
-1,893
-436.886
-298.885
-432.528
Accounts receivable
794.682
-94.286
378.681
67.089
-50.135
Inventory
-1,340
-2,807
451.122
-728.801
47.056
Accounts Payable
-142.359
1,277
-680.697
479.181
-14.244
Other working capital
-7,653
-7,452
-10,719
-8,055
-6,201
Other non-cash items
346.868
106.523
775.856
-940.936
666.743
Net cash provided by operating activites
-7,649
-7,447
-10,644
-8,014
-6,030
Cash flows from investing activities
Investments in property, plant and equipment
-3.352
-5.569
-74.592
-40.733
-171.076
Acquisitions, net
94.916
0
-25,941
-
-
Purchases of investments
-85,568
-77,592
-70,953
-
-
Sales/Maturities of investments
92,563
82,587
65,957
-
-
Net cash used for investing activites
7,086
4,990
-31,011
-34.733
-171.076
Cash flows from financing activities
Debt repayment
-
-
-
0
-100.548
Common stock issued
8,835
8,835
33,663
0
16,225
Common stock repurchased
-9.033
-9.033
-
-
-
Net cash used privided by (used for) financing activities
9,945
14,268
37,231
5,452
16,646
Net change in cash
9,382
11,812
-4,425
-2,597
10,445
Cash at beginning of period
3,564
4,094
8,519
11,116
670.948
Cash at end of period
12,946
15,905
4,094
8,519
11,116
Free Cash Flow
Operating Cash Flow
-7,649
-7,447
-10,644
-8,014
-6,030
Capital Expenditure
-3.352
-5.569
-74.592
-40.733
-171.076
Free Cash Flow
-7,653
-7,452
-10,719
-8,055
-6,201